Discontinuation of GLP-1 Receptor Agonists

Comparison with Other Medications

• The Centers for Disease Control and Prevention recommends tapering protocols for opioids, benzodiazepines, and antipsychotics, which cause neuroadaptive changes requiring gradual dose reduction, in contrast to GLP-1 receptor agonists like semaglutide 1, 2, 3